Aptevo Therapeutics Inc.
13F holders, Q2 2024 (June 30)18holders +8
9new positions
1sold out
$0.31avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Aptevo Therapeutics Inc. in their 13F filings, up 8 from Q1 2024. 9 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($229K), Sabby Management, LLC ($153K) and Hudson Bay Capital Management LP ($153K).
- Company
- Aptevo Therapeutics Inc.
- CUSIP
- 03835L306
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $596K |
| Exits | 1 | $9 |
All 13F filers, Q1 2024 → Q2 2024: 1,961,109 shares bought and 7 shares sold, net +1,961,102 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Armistice Capital, LLC | 0.01% | New | 749,234 | $229K |
| Sabby Management, LLC | 2.29% | New | 501,499 | $153K |
| Hudson Bay Capital Management LP | 0.00% | New | 500,000 | $153K |
| UBS Group AG | 0.00% | New | 115,910 | $35K |
| HRT Financial LP | 0.00% | New | 30,560 | $9K |
| Geode Capital Management, LLC | 0.00% | New | 19,385 | $6K |
| Baader Bank Aktiengesellschaft | 0.00% | New | 20,152 | $5K |
| Virtu Financial LLC | 0.00% | New | 17,395 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +484.4% | 7,738 | $2K |
| BlackRock Inc. | 0.00% | Reduce -0.2% | 888 | $272 |
| Qube Research & Technologies Ltd | 0.00% | Add +400.0% | 500 | $153 |
| Morgan Stanley | 0.00% | No change | 194 | $60 |
| Bank of America Corp. | 0.00% | New | 160 | $49 |
| JPMorgan Chase & Co. | 0.00% | No change | 43 | $13 |
| Osaic Holdings, Inc. | 0.00% | No change | 45 | $13 |
| Wells Fargo & Company | 0.00% | Reduce -8.3% | 33 | $10 |
| Fifth Third Bancorp | 0.00% | No change | 6 | $2 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 3 | $1 |
"% of holder's portfolio" is APTEVO THERAPEUTICS INC's weight in each manager's 13F, not the share of Aptevo Therapeutics Inc. the manager owns.